Find out what’s new and what’s next in treatment options for EC.
-
-
Reduced lenvatinib dose for EC improves safety but lowers efficacy
-
Including EC patients of all ages key to more accurate research
-
Physical activity may lead to better outcomes in endometrial cancer
-
What are antibody-drug conjugates for endometrial cancer?
-
Ibuprofen linked to reduced risk of endometrial cancer
-
Potential EC therapy receives Breakthrough Therapy Designation from FDA